RE:Decent price moveFourth time since Feb. that we've hit the infamous $1.57 from whence the SP has allways drifted back to $1.37ish - then bounced around in between. My guess is we're rangebound as ever but I hope to be proven wrong - a breakout above the accursed number would be nice but as DF has indicated it all depends on what the big boys want and when they want it. What was the number? A Big Pharma competitor could hold 4% of the company and not even have to declare it? Happy about the uplist but still cautious as volume continues to disappoint (for now).